Type 2 Diabetes Trial, By Invitation NCT06826807 Sponsor: Mahidol University Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, By Invitation

NCT06826807
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with a condition called MASLD (a type of fatty liver disease), confirmed by evidence of fat in the liver, limited alcohol intake (less than 140 grams per week for females or less than 210 grams per week for males), and at least one feature of metabolic syndrome (such as high blood pressure, high blood sugar, or obesity).
  • People who are aged 18 years or older and under 80 years old at the time of joining the trial.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have been diagnosed with another long-term liver condition, such as hepatitis B or C, autoimmune hepatitis, Wilson's disease, liver cancer, hemochromatosis, or liver cirrhosis.
  • People who have conditions that may affect their fatty liver disease, such as HIV, long-term inflammatory diseases, or connective tissue disorders.
  • People who are currently taking certain medications known to contribute to fatty liver disease, including amiodarone, steroids, methotrexate, hormonal medications, or immunosuppressants.
  • People who have previously taken certain medications known to affect fatty liver disease, including vitamin E, pioglitazone, GLP-1 receptor agonists, or SGLT2 inhibitors (confirm with trial site for specific medications).
  • People who are planning to join a weight loss program or have bariatric (weight loss) surgery during the trial.
  • People who have serious long-term conditions that cause symptoms during physical activity — such as significant heart disease, severe lung disease, or severe joint problems — that could be made worse by exercise.
  • People who are unable to have an MRI scan, for example due to claustrophobia (fear of enclosed spaces) or having certain implants or metal materials in their body that are not compatible with MRI.
  • People who are pregnant.
  • People who do not provide formal written consent to take part in the research.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 18 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Mahidol University
Registry
ClinicalTrials.gov
Start date
12 May 2025
Est. completion
1 January 2027

Where this trial is recruiting

🇹🇭 Thailand

Primary endpoints

Change from baseline in non-invasive marker magnetic resonance imaging-estimated proton density fat fraction (MRI-PDFF) (%)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov